Six months ago the pps advanced steadly up to .0039 approaching the previous high of .005 on news that their innovative products were being considered for approval by the FDA. The anticipated approval along with a partnership deal would have accelerated Biel's pps with speculation it could even reach .02-.03 cents a share. I expect the same enthusiasm for Biel's success is forth coming with announcements that are sure to come with all the developments behind the scenes and on the international stage. Huge potential here.
(2)
(0)
BioElectronics Corporation (BIEL) Stock Research Links